Rethinking mental health research through AI-driven simulations

Recent research highlights generative agents’ potential to model complex socio-environmental interactions, transforming mental health studies and interventions.

Sage suggests job and pipeline cuts after FDA rejection of major depression pill

Sage Therapeutics announced plans for a “pipeline prioritization and a workforce reorganization” on Monday morning after the FDA rejected its experimental pill for major depressive

August 8, 2023

Pemafibrate Takes a Small Step Forward in Diabetic Foot Ulcers After CVD Flop

Pemafibrate was tied to potential prevention of leg and foot ulcers in type 2 diabetes, a silver lining to the PROMINENT trial’s otherwise disappointing cardiovascular

July 16, 2024

Surgeon general calls for labels warning of cancer risk on alcohol

The U.S. surgeon general on Friday called for alcoholic beverages to carry labels warning of their connection to cancer, just as cigarettes do. The recommendation

January 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.